• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

Recent Advances in the Study of 3-Nitro-2-(piperidin-1-yl)pyridine (CAS: 26930-71-2)

3-Nitro-2-(piperidin-1-yl)pyridine (CAS: 26930-71-2) is a chemical compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have focused on its synthesis, biological activity, and mechanistic insights, shedding light on its role as a promising scaffold for therapeutic agents. This research brief aims to summarize the latest findings related to this compound, providing a comprehensive overview for professionals in the field.

The compound's structure, featuring a nitro group and a piperidine moiety, makes it a versatile intermediate in the synthesis of various pharmacologically active molecules. Recent research has explored its utility in the development of kinase inhibitors, antimicrobial agents, and anti-inflammatory compounds. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 3-Nitro-2-(piperidin-1-yl)pyridine exhibit potent inhibitory activity against specific protein kinases, highlighting its potential in cancer therapy.

In addition to its kinase inhibitory properties, 3-Nitro-2-(piperidin-1-yl)pyridine has been investigated for its antimicrobial effects. A study conducted by researchers at the University of Cambridge revealed that certain analogs of this compound display significant activity against drug-resistant bacterial strains, including MRSA. The study, published in Bioorganic & Medicinal Chemistry Letters, identified the nitro group as a critical pharmacophore for antibacterial activity, suggesting avenues for further optimization.

Mechanistic studies have also provided insights into the compound's mode of action. Nuclear magnetic resonance (NMR) and X-ray crystallography analyses have elucidated the binding interactions of 3-Nitro-2-(piperidin-1-yl)pyridine with target proteins, offering a structural basis for its biological effects. These findings, reported in a 2024 issue of ACS Chemical Biology, underscore the compound's potential as a lead structure for rational drug design.

Despite these promising results, challenges remain in the development of 3-Nitro-2-(piperidin-1-yl)pyridine-based therapeutics. Issues such as solubility, bioavailability, and off-target effects need to be addressed through further chemical modifications and preclinical studies. Ongoing research aims to optimize the compound's pharmacokinetic properties while maintaining its efficacy, as highlighted in a recent review article in Drug Discovery Today.

In conclusion, 3-Nitro-2-(piperidin-1-yl)pyridine (CAS: 26930-71-2) represents a valuable scaffold in medicinal chemistry, with demonstrated potential in kinase inhibition and antimicrobial therapy. Continued research efforts are expected to yield novel derivatives with enhanced therapeutic profiles, paving the way for clinical applications. This brief underscores the importance of interdisciplinary collaboration in advancing the understanding and utilization of this compound in drug discovery.

• 26820-73-5(Pyridine,3-nitro-2-(1-pyrrolidinyl)-)
• 671191-99-4(1-(3-Nitropyridin-2-yl)piperidine-4-carbonitrile)
• 878398-55-1(Pyridine, 2-(3-cyclohexyl-1-piperidinyl)-3-nitro-)
• 1420963-58-1((1-(3-Nitropyridin-2-yl)piperidin-3-yl)methanamine hydrochloride)
• 1420850-17-4((1-(3-Nitropyridin-2-yl)piperidin-4-yl)methanamine hydrochloride)
• 1170160-07-2(4-Hydroxy-1-(3-nitropyridin-2-yl)piperidine Hydrochloride)
• 1235440-20-6(1-(3-Nitropyridin-2-yl)piperidin-4-ylmethanol)
• 878400-94-3(Pyridine, 2-[1,4'-bipiperidin]-1'-yl-3-nitro-)
• 338411-78-2(1-(3-Nitro-2-pyridinyl)-4-piperidinol)
• 848498-92-0(1-(3-Nitropyridin-2-yl)piperidin-4-amine dihydrochloride)